MicroSeal Hip System Problems Result in Warning Letter to Signal
Signal Medical has received an FDA warning letter for altering the design of its Microseal hip replacement system without FDA approval.
May 28, 2015 By: Russell Maas
Signal Medical has received an FDA warning letter for altering the design of its Microseal hip replacement system without FDA approval.
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.
A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.